Physician profile
Vipul Gupta
NPI 1376781575
$1,280.49
in general payments reported to CMS, 2019-2025
20 companies · $464 in 2025
The $464 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.18 · 2020: $62.78 · 2021: $97.83 · 2022: $294 · 2023: $132 · 2024: $182 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $458.04 | 2021-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.19 | 2019-2024 | Lifevest |
| Medtronic, INC. | $114.75 | 2021-2025 | Symplicity G3, Linq II, Ffrangio |
| Philips North America LLC | $73.90 | 2024-2025 | Coronary Other, (Bq9) Coronary Ivus, Omniwire |
| Shockwave Medical, INC | $67.63 | 2022 | |
| Medtronic Vascular, INC. | $56.38 | 2019-2020 | |
| Baxter Healthcare | $50.14 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Janssen Pharmaceuticals, INC | $45.82 | 2021 | |
| Irhythm Technologies, INC. | $35.52 | 2019-2023 | Zio Xt Patch |
| Scpharmaceuticals INC. | $34.10 | 2025 | |
| Boston Scientific Corporation | $32.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $31.52 | 2021-2025 | Farxiga |
| Impulse Dynamics (USA) INC. | $25.33 | 2023 | Optimizer |
| Heartflow, INC. | $23.95 | 2024 | |
| Preventice Services, LLC | $22.95 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.42 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $19.52 | 2023 | Arcalyst |
| Lilly USA, LLC | $18.92 | 2025 | Zepbound, Mounjaro |
| Cook Medical LLC | $17.03 | 2024 | Cook |
| Terumo Medical Corporation | $14.17 | 2025 | Metacross Otw |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vipul Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.